Related Experiment Video
Updated: Sep 30, 2025
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy
Fabrizio Fontana1, Martina Anselmi1, Patrizia Limonta1
1Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Abstract:
Prostate cancer remains one of the most lethal malignancies among men worldwide. Although the primary tumor can be successfully managed by surgery and radiotherapy, advanced metastatic carcinoma requires better therapeutic approaches. In this context, a deeper understanding of the molecular mechanisms that underlie the initiation and progression of this disease is urgently needed, leading to the identification of new diagnostic/prognostic markers and the development of more effective treatments. Herein, the current state of knowledge of prostate cancer genetic alterations is discussed, with a focus on their potential in tumor detection and staging as well as in the screening of novel therapeutics.
Insights
Prostate cancer is a lethal malignancy requiring better treatments for advanced stages. Understanding genetic alterations is key for developing new diagnostic markers and effective therapies for prostate cancer.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Prostate cancer is a leading cause of cancer death in men globally.
- Current treatments are effective for primary tumors but insufficient for metastatic disease.
- Advanced prostate cancer necessitates improved therapeutic strategies.
Purpose of the Study:
- To review the current understanding of genetic alterations in prostate cancer.
- To explore the potential of these alterations in diagnostics and prognostics.
- To identify novel therapeutic targets for prostate cancer treatment.
Main Methods:
- Literature review of genetic alterations in prostate cancer.
- Analysis of the role of genetic changes in tumor initiation and progression.
- Evaluation of genetic markers for diagnostic and therapeutic applications.
Main Results:
- Prostate cancer is characterized by numerous genetic alterations.
- Specific genetic changes are linked to tumor detection, staging, and progression.
- Genetic alterations offer potential for developing targeted therapies.
Conclusions:
- A comprehensive understanding of prostate cancer genetics is crucial.
- Genetic alterations can serve as biomarkers for improved prostate cancer management.
- Targeting genetic pathways holds promise for novel prostate cancer therapeutics.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers